Cargando…

High expression of GMNN predicts malignant progression and poor prognosis in ACC

BACKGROUND: Adrenocortical carcinoma (ACC) is a rare endocrine neoplasm, which is characterized by poor prognosis and high recurrence rate. Novel and reliable prognostic and metastatic biomarkers are lacking for ACC patients. This study aims at screening potential prognostic biomarkers and therapeut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Xinzhao, Zhang, Xuezhou, Shao, Shixiu, Yang, Qingbo, Shen, Chengquan, Yang, Xuecheng, Jiao, Wei, Liu, Jing, Wang, Yonghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764478/ https://www.ncbi.nlm.nih.gov/pubmed/36539849 http://dx.doi.org/10.1186/s40001-022-00950-2

Ejemplares similares

High expression of COL6A1 predicts poor prognosis and response to immunotherapy in bladder cancer
por: Zhang, Xuezhou, et al.
Publicado: (2022)

TOP2A Promotes Lung Adenocarcinoma Cells' Malignant Progression and Predicts Poor Prognosis in Lung Adenocarcinoma
por: Kou, Fan, et al.
Publicado: (2020)

Frequent Amplification of CENPF, GMNN and CDK13 Genes in Hepatocellular Carcinomas
por: Kim, Hye-Eun, et al.
Publicado: (2012)

Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma
por: Shen, Chengquan, et al.
Publicado: (2021)

Efficient Knock-in of a Point Mutation in Porcine Fibroblasts Using the CRISPR/Cas9-GMNN Fusion Gene
por: Gerlach, Max, et al.
Publicado: (2018)

Shoot-to-root translocated GmNN1/FT2a triggers nodulation and regulates soybean nitrogen nutrition
por: Li, Xinxin, et al.
Publicado: (2022)

Generation of Functional Hepatocytes from Human Adipose‐Derived MYC(+) KLF4(+) GMNN(+) Stem Cells Analyzed by Single‐Cell RNA‐Seq Profiling
por: Li, Hongling, et al.
Publicado: (2018)

Overexpression of S100A14 contributes to malignant progression and predicts poor prognosis of lung adenocarcinoma
por: Ding, Fang, et al.
Publicado: (2018)

Adrenocortical carcinoma (ACC): diagnosis, prognosis, and treatment
por: Libé, Rossella
Publicado: (2015)

Downregulation of ACC expression suppresses cell viability and migration in the malignant progression of breast cancer
por: Jin, Mei, et al.
Publicado: (2023)

Loss of Cirbp expression is correlated with the malignant progression and poor prognosis in nasopharyngeal carcinoma
por: Lin, Tao-Yan, et al.
Publicado: (2019)

SERPINE1 Overexpression Promotes Malignant Progression and Poor Prognosis of Gastric Cancer
por: Chen, Shujia, et al.
Publicado: (2022)

c-Fos over-expression promotes radioresistance and predicts poor prognosis in malignant glioma
por: Liu, Zhi-Gang, et al.
Publicado: (2016)

Overexpression of CDCA8 promotes the malignant progression of cutaneous melanoma and leads to poor prognosis
por: Ci, Chao, et al.
Publicado: (2019)

Hornerin promotes tumor progression and is associated with poor prognosis in hepatocellular carcinoma
por: Fu, Shun-Jun, et al.
Publicado: (2018)

Overexpression of FRAT1 Is Associated with Malignant Phenotype and Poor Prognosis in Human Gliomas
por: Guo, Geng, et al.
Publicado: (2015)

Ethylene, ACC, and the Plant Growth-Promoting Enzyme ACC Deaminase
por: Gamalero, Elisa, et al.
Publicado: (2023)

High HDAC9 is associated with poor prognosis and promotes malignant progression in pancreatic ductal adenocarcinoma
por: Li, He, et al.
Publicado: (2020)

Long non-coding RNA XIST predicts poor prognosis and promotes malignant phenotypes in osteosarcoma
por: Wang, Wei, et al.
Publicado: (2019)

ELK1 Enhances Pancreatic Cancer Progression Via LGMN and Correlates with Poor Prognosis
por: Yan, Qiang, et al.
Publicado: (2021)

The Analysis of PTPN6 for Bladder Cancer: An Exploratory Study Based on TCGA
por: Shen, Chengquan, et al.
Publicado: (2020)

ATF2 predicts poor prognosis and promotes malignant phenotypes in renal cell carcinoma
por: Wu, Deng-shuang, et al.
Publicado: (2016)

Clonal heterogeneity of lymphoid malignancies correlates with poor prognosis
por: Suguro, Miyuki, et al.
Publicado: (2014)

GABRD promotes progression and predicts poor prognosis in colorectal cancer
por: Niu, Gengming, et al.
Publicado: (2020)

Loss of alanine-glyoxylate and serine-pyruvate aminotransferase expression accelerated the progression of hepatocellular carcinoma and predicted poor prognosis
por: Sun, Yufeng, et al.
Publicado: (2019)

ASPM May be Related to the Malignant Progression of Hepatitis B and is Associated With a Poor Prognosis of Hepatocellular Carcinoma
por: Tan, Siyou, et al.
Publicado: (2022)

Elevated pretreatment platelet distribution width and platelet count predict poor prognosis in nasopharyngeal carcinoma
por: Xie, XueCheng, et al.
Publicado: (2017)

A pain in the ACC
por: Frankland, Paul W, et al.
Publicado: (2005)

PS acces beams
por: CERN. Geneva. Audiovisual Unit
Publicado: (1995)

UBN2 promotes tumor progression via the Ras/MAPK pathway and predicts poor prognosis in colorectal cancer
por: Zhao, Ya-li, et al.
Publicado: (2019)

Dominant Gene Expression Profiles Define Adenoid Cystic Carcinoma (ACC) from Different Tissues: Validation of a Gene Signature Classifier for Poor Survival in Salivary Gland ACC
por: Brayer, Kathryn J., et al.
Publicado: (2023)

High miR-454-3p expression predicts poor prognosis in hepatocellular carcinoma
por: Li, Yanqing, et al.
Publicado: (2019)

Overexpression of JAB1 promotes malignant behavior and predicts poor prognosis in esophageal squamous cell carcinoma
por: Shen, Qi, et al.
Publicado: (2020)

Upregulation of long noncoding RNA HOXA-AS3 promotes tumor progression and predicts poor prognosis in glioma
por: Wu, Fan, et al.
Publicado: (2017)

TMEM106C contributes to the malignant characteristics and poor prognosis of hepatocellular carcinoma
por: Duan, Jicheng, et al.
Publicado: (2021)

Low UGP2 Expression Is Associated with Tumour Progression and Predicts Poor Prognosis in Hepatocellular Carcinoma
por: Hu, Qiuyue, et al.
Publicado: (2020)

Upregulation of AKIP1 contributes to metastasis and progression and predicts poor prognosis of patients with colorectal cancer
por: Jiang, Weifang, et al.
Publicado: (2018)

SMO mutations confer poor prognosis in malignant pleural mesothelioma
por: Signorelli, Diego, et al.
Publicado: (2020)

KCNH3 Predicts Poor Prognosis and Promotes Progression in Ovarian Cancer
por: Li, Zhongjun, et al.
Publicado: (2020)

NSUN5 promotes progression and predicts poor prognosis in hepatocellular carcinoma
por: Zhang, Xiao-Wen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_11hiiu1cd9hrg01vagvefofv48